Aimed Alliance and HR.com have launched a new webpage highlighting our 2024 survey findings; infographic, and webinar for employers and…
The Oregon Prescription Drug Affordability Board is currently reviewing the affordability of 27 selected medications and has requested feedback from…
On April 22, 2025, Aimed Alliance released a new resource titled “Tariffs 101: How Tariffs Could Impact Patients.” Since the start…
The 2025 Open Enrollment period is fast approaching! The 2025 Open Enrollment period of individuals, small group and large group…
On September 20th, 2024, the Federal Trade Commission (FTC) filed a complaint against Express Scripts, CVS Caremark, and OptumRx –…
California Governor Gavin Newsom signed into law two new healthcare-related artificial intelligence (AI) bills that introduce regulations for payers using…
On September 30, 2024, the Centers for Medicare & Medicaid Services (CMS) announced its decision to cover all forms of…
During the 2024 legislative session, Vermont passed a step-therapy law that placed guardrails on step-therapy policies to protect health care…
On August 28, 2024, The AIDS Institute released an analysis revealing that despite laws banning copay accumulator policies, health insurance…
At its September 10th meeting, the Maryland Prescription Drug Affordability Board (PDAB) approved its upper payment limit (UPL) action plan…